Unlocking the health benefits of cannabinoids.

We are a team of medical experts.

Medical Advisory Board

Our Medical Advisory Board is made up of renowned Healthcare Professionals whose unique perspectives and expertise inform the strategic direction and success of the company.

Political Advisory Board

Our Political Advisory Board comprises renowned political experts and healthcare professionals who provide strategic guidance and advice to support Sanity Group to meet its mission and objectives.

Latest News

Cannabis legalization in Germany – Statement on the revised cornerstone paper

Today, the German government presented a revised cornerstone paper for the planned cannabis legalization. According to that, cannabis will be allowed to be cultivated in certain quantities privately and in Cannabis Social Clubs, in a second step there will also be regional pilot projects. Finn Hänsel, CEO of Berlin-based cannabis company Sanity Group, comments on this in a first statement.

Read more

Endosane Pharmaceuticals agrees to Licence Agreement with PreveCeutical Medical thereby Securing Exclusive Rights to Innovative Technology

Berlin/Vancouver, January 16, 2023 – Endosane Pharmaceuticals, a Berlin-based pharmaceutical company, and PreveCeutical Medical Inc. (CSE: PREV, OTCQB: PRVCF, FSE: 18H) of Canada have entered into a licensing agreement through which Endosane Pharmaceuticals has obtained exclusive access and use rights to the Sol-Gel technology developed by PreveCeutical Medical for the delivery of cannabinoid products.

Read more

Sanity Group welcomes aspects of the official document outlining the key points on cannabis legalization, but sees room for improvement

Today, the official cornerstone paper of the German government on the controlled dispensing of cannabis to adults for consumption purposes was presented. This follows details released from an internal, non-coordinated draft that became public last week. From the point of view of Sanity Group, one of the leading cannabis companies in Germany, the final and revised version contains interesting approaches and some fruitful frameworks, but the Berlin-based company is critical of certain points.

Read more